The 2.4 mg maintenance dose is close to the 1 mL capacity of a standard U-100 insulin syringe, which is why some community sources reconstitute cagrilintide at higher concentration (e.g., 5 mg in 1.5 mL 3.33 mg/mL 2.4 mg = 0.72 mL = 72 units) to keep dose volume manageable
By way of example only, the auris-acceptable viscosity agent includes hydroxypropyl methylcellulose, hydroxyethyl cellulose, polyvinylpyrrolidone, carboxymethyl cellulose, polyvinyl alcohol, sodium chondroitin sulfate, sodium hyaluronate
doi: 10.1111/j.1751-553X.2008.01115.x Barbara M Rhode et al
[145:18] Jamie Whoa
Additive Manufacturing , 8 , 3662
The annual congress of the European Hematology Association (EHA) is widely recognized as one of the most influential global forums for advances in hematology, bringing together clinicians, researchers, patient advocates, regulators, and industry leaders to shape the future of care for patients with blood disorders